Central Depository Services (India) Ltd: Share Price Analysis, Intrinsic Value & Fundamentals (2025)

Share Price and Basic Stock Data

Last Updated: March 13, 2025, 4:14 pm

Competitors of Central Depository Services (India) Ltd

All Competitor Stocks of Central Depository Services (India) Ltd

Quarterly Result

Last Updated: February 28, 2025, 8:24 pm

Below is a detailed analysis of the quarterly data for Central Depository Services (India) Ltd based on the most recent figures (Dec 2024) and their trends compared to the previous period:

• For Sales, as of Dec 2024, the value is ₹278.00 Cr.. The value appears to be declining and may need further review. It has decreased from 322.00 Cr. (Sep 2024) to ₹278.00 Cr., marking a decrease of 44.00 Cr..
• For Expenses, as of Dec 2024, the value is ₹117.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 122.00 Cr. (Sep 2024) to ₹117.00 Cr., marking a decrease of 5.00 Cr..
• For Operating Profit, as of Dec 2024, the value is ₹161.00 Cr.. The value appears to be declining and may need further review. It has decreased from 200.00 Cr. (Sep 2024) to ₹161.00 Cr., marking a decrease of 39.00 Cr..
• For OPM %, as of Dec 2024, the value is 58.00%. The value appears to be declining and may need further review. It has decreased from 62.00% (Sep 2024) to 58.00%, marking a decrease of 4.00%.
• For Other Income, as of Dec 2024, the value is ₹21.00 Cr.. The value appears to be declining and may need further review. It has decreased from 37.00 Cr. (Sep 2024) to ₹21.00 Cr., marking a decrease of 16.00 Cr..
• For Interest, as of Dec 2024, the value is ₹0.00 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2024) which recorded 0.00 Cr..
• For Depreciation, as of Dec 2024, the value is ₹13.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 12.00 Cr. (Sep 2024) to ₹13.00 Cr., marking an increase of ₹1.00 Cr..
• For Profit before tax, as of Dec 2024, the value is ₹168.00 Cr.. The value appears to be declining and may need further review. It has decreased from 225.00 Cr. (Sep 2024) to ₹168.00 Cr., marking a decrease of 57.00 Cr..
• For Tax %, as of Dec 2024, the value is 23.00%. The value appears to be improving (decreasing) as expected. It has decreased from 28.00% (Sep 2024) to 23.00%, marking a decrease of 5.00%.
• For Net Profit, as of Dec 2024, the value is ₹130.00 Cr.. The value appears to be declining and may need further review. It has decreased from 162.00 Cr. (Sep 2024) to ₹130.00 Cr., marking a decrease of 32.00 Cr..
• For EPS in Rs, as of Dec 2024, the value is 6.22. The value appears to be declining and may need further review. It has decreased from ₹7.75 (Sep 2024) to 6.22, marking a decrease of ₹1.53.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: March 6, 2025, 4:36 pm

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: November 15, 2024, 1:32 am

Below is a detailed analysis of the balance sheet data for Central Depository Services (India) Ltd based on the most recent figures (Sep 2024) and their trends compared to the previous period:

• For Equity Capital, as of Sep 2024, the value is ₹209.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹104.00 Cr. (Mar 2024) to ₹209.00 Cr., marking an increase of 105.00 Cr..
• For Reserves, as of Sep 2024, the value is ₹1,320.00 Cr.. The value appears to be declining and may need further review. It has decreased from ₹1,359.00 Cr. (Mar 2024) to ₹1,320.00 Cr., marking a decrease of 39.00 Cr..
• For Borrowings, as of Sep 2024, the value is ₹1.00 Cr.. The value remains steady. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. There is no change compared to the previous period (Mar 2024) which recorded ₹1.00 Cr..
• For Other Liabilities, as of Sep 2024, the value is ₹518.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from ₹317.00 Cr. (Mar 2024) to ₹518.00 Cr., marking an increase of 201.00 Cr..
• For Total Liabilities, as of Sep 2024, the value is ₹2,048.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from ₹1,781.00 Cr. (Mar 2024) to ₹2,048.00 Cr., marking an increase of 267.00 Cr..
• For Fixed Assets, as of Sep 2024, the value is ₹375.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹342.00 Cr. (Mar 2024) to ₹375.00 Cr., marking an increase of 33.00 Cr..
• For CWIP, as of Sep 2024, the value is ₹4.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded ₹4.00 Cr..
• For Investments, as of Sep 2024, the value is ₹1,247.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹1,149.00 Cr. (Mar 2024) to ₹1,247.00 Cr., marking an increase of 98.00 Cr..
• For Other Assets, as of Sep 2024, the value is ₹423.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹287.00 Cr. (Mar 2024) to ₹423.00 Cr., marking an increase of 136.00 Cr..
• For Total Assets, as of Sep 2024, the value is ₹2,048.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹1,781.00 Cr. (Mar 2024) to ₹2,048.00 Cr., marking an increase of 267.00 Cr..

Notably, the Reserves (₹1,320.00 Cr.) exceed the Borrowings (1.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Central Depository Services (India) Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 24, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 24, the value is 40.11. This value is within the healthy range. It has increased from 26.41 (Mar 23) to 40.11, marking an increase of 13.70.
• For Diluted EPS (Rs.), as of Mar 24, the value is 40.11. This value is within the healthy range. It has increased from 26.41 (Mar 23) to 40.11, marking an increase of 13.70.
• For Cash EPS (Rs.), as of Mar 24, the value is 42.86. This value is within the healthy range. It has increased from 28.70 (Mar 23) to 42.86, marking an increase of 14.16.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 144.23. It has increased from 120.30 (Mar 23) to 144.23, marking an increase of 23.93.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 144.23. It has increased from 120.30 (Mar 23) to 144.23, marking an increase of 23.93.
• For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 77.73. It has increased from 53.12 (Mar 23) to 77.73, marking an increase of 24.61.
• For PBDIT / Share (Rs.), as of Mar 24, the value is 55.93. This value is within the healthy range. It has increased from 37.24 (Mar 23) to 55.93, marking an increase of 18.69.
• For PBIT / Share (Rs.), as of Mar 24, the value is 53.32. This value is within the healthy range. It has increased from 35.38 (Mar 23) to 53.32, marking an increase of 17.94.
• For PBT / Share (Rs.), as of Mar 24, the value is 53.31. This value is within the healthy range. It has increased from 35.37 (Mar 23) to 53.31, marking an increase of 17.94.
• For Net Profit / Share (Rs.), as of Mar 24, the value is 40.25. This value is within the healthy range. It has increased from 26.83 (Mar 23) to 40.25, marking an increase of 13.42.
• For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 40.10. This value is within the healthy range. It has increased from 26.41 (Mar 23) to 40.10, marking an increase of 13.69.
• For PBDIT Margin (%), as of Mar 24, the value is 71.95. This value is within the healthy range. It has increased from 70.11 (Mar 23) to 71.95, marking an increase of 1.84.
• For PBIT Margin (%), as of Mar 24, the value is 68.59. This value exceeds the healthy maximum of 20. It has increased from 66.60 (Mar 23) to 68.59, marking an increase of 1.99.
• For PBT Margin (%), as of Mar 24, the value is 68.58. This value is within the healthy range. It has increased from 66.58 (Mar 23) to 68.58, marking an increase of 2.00.
• For Net Profit Margin (%), as of Mar 24, the value is 51.78. This value exceeds the healthy maximum of 10. It has increased from 50.51 (Mar 23) to 51.78, marking an increase of 1.27.
• For NP After MI And SOA Margin (%), as of Mar 24, the value is 51.59. This value exceeds the healthy maximum of 20. It has increased from 49.71 (Mar 23) to 51.59, marking an increase of 1.88.
• For Return on Networth / Equity (%), as of Mar 24, the value is 28.64. This value is within the healthy range. It has increased from 22.73 (Mar 23) to 28.64, marking an increase of 5.91.
• For Return on Capital Employeed (%), as of Mar 24, the value is 36.14. This value is within the healthy range. It has increased from 29.04 (Mar 23) to 36.14, marking an increase of 7.10.
• For Return On Assets (%), as of Mar 24, the value is 23.52. This value is within the healthy range. It has increased from 18.93 (Mar 23) to 23.52, marking an increase of 4.59.
• For Asset Turnover Ratio (%), as of Mar 24, the value is 0.50. It has increased from 0.39 (Mar 23) to 0.50, marking an increase of 0.11.
• For Current Ratio (X), as of Mar 24, the value is 3.33. This value exceeds the healthy maximum of 3. It has decreased from 3.56 (Mar 23) to 3.33, marking a decrease of 0.23.
• For Quick Ratio (X), as of Mar 24, the value is 3.33. This value exceeds the healthy maximum of 2. It has decreased from 3.56 (Mar 23) to 3.33, marking a decrease of 0.23.
• For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 39.89. This value is within the healthy range. It has decreased from 56.80 (Mar 23) to 39.89, marking a decrease of 16.91.
• For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 37.46. This value is within the healthy range. It has decreased from 53.06 (Mar 23) to 37.46, marking a decrease of 15.60.
• For Earning Retention Ratio (%), as of Mar 24, the value is 60.11. This value is within the healthy range. It has increased from 43.20 (Mar 23) to 60.11, marking an increase of 16.91.
• For Cash Earning Retention Ratio (%), as of Mar 24, the value is 62.54. This value is within the healthy range. It has increased from 46.94 (Mar 23) to 62.54, marking an increase of 15.60.
• For Interest Coverage Ratio (X), as of Mar 24, the value is 5,308.25. This value is within the healthy range. It has increased from 2,915.29 (Mar 23) to 5,308.25, marking an increase of 2,392.96.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 3,821.50. This value is within the healthy range. It has increased from 2,101.25 (Mar 23) to 3,821.50, marking an increase of 1,720.25.
• For Enterprise Value (Cr.), as of Mar 24, the value is 17,880.86. It has increased from 9,416.34 (Mar 23) to 17,880.86, marking an increase of 8,464.52.
• For EV / Net Operating Revenue (X), as of Mar 24, the value is 22.01. This value exceeds the healthy maximum of 3. It has increased from 16.96 (Mar 23) to 22.01, marking an increase of 5.05.
• For EV / EBITDA (X), as of Mar 24, the value is 30.59. This value exceeds the healthy maximum of 15. It has increased from 24.19 (Mar 23) to 30.59, marking an increase of 6.40.
• For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 22.02. This value exceeds the healthy maximum of 3. It has increased from 17.11 (Mar 23) to 22.02, marking an increase of 4.91.
• For Retention Ratios (%), as of Mar 24, the value is 60.10. This value is within the healthy range. It has increased from 43.19 (Mar 23) to 60.10, marking an increase of 16.91.
• For Price / BV (X), as of Mar 24, the value is 12.23. This value exceeds the healthy maximum of 3. It has increased from 7.82 (Mar 23) to 12.23, marking an increase of 4.41.
• For Price / Net Operating Revenue (X), as of Mar 24, the value is 22.03. This value exceeds the healthy maximum of 3. It has increased from 17.11 (Mar 23) to 22.03, marking an increase of 4.92.
• For EarningsYield, as of Mar 24, the value is 0.02. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 23) which recorded 0.02.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness